左炔诺孕酮宫内节育系统的非避孕用途。
Non-contraceptive applications of the levonorgestrel intrauterine system.
机构信息
Department of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco General Hospital and Bixby Center for Global Reproductive Health, University of California, San Francisco, CA, USA.
出版信息
Int J Womens Health. 2010 Aug 9;2:63-8. doi: 10.2147/ijwh.s6344.
Abstract
Intrauterine progestins have many important current and potential gynecologic applications. This article describes the evidence for use of intrauterine progestin for common gynecologic conditions beyond its important role in contraception. The pharmacology of and selection criteria for use of the levonorgestrel intrauterine device is discussed, and the evidence for use of intrauterine progestin delivery for menorrhagia, endometriosis management, uterine fibroids, adenomyosis and endometrial hyperplasia is reviewed.
摘要
宫内孕激素在妇科领域有许多重要的当前和潜在应用。本文介绍了除避孕作用外，宫内孕激素在常见妇科疾病中的应用证据。讨论了左炔诺孕酮宫内节育器的药理学和使用选择标准，并回顾了宫内孕激素用于月经过多、子宫内膜异位症管理、子宫肌瘤、子宫腺肌病和子宫内膜增生的证据。
相似文献
1
Non-contraceptive applications of the levonorgestrel intrauterine system.
Int J Womens Health. 2010 Aug 9;2:63-8. doi: 10.2147/ijwh.s6344.
2
Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications.
Am J Obstet Gynecol. 2010 May;202(5):420-8. doi: 10.1016/j.ajog.2009.10.863. Epub 2009 Dec 23.
3
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006.
4
Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Contraception. 1999 Sep;60(3):173-5. doi: 10.1016/s0010-7824(99)00075-x.
5
Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
Fertil Steril. 1997 Sep;68(3):426-9. doi: 10.1016/s0015-0282(97)00245-8.
6
Levonorgestrel-releasing intrauterine system: uses and controversies.
Expert Rev Med Devices. 2008 Jul;5(4):437-45. doi: 10.1586/17434440.5.4.437.
7
Laevonorgestrel intra-uterine system--a revolutionary intra-uterine device.
J Indian Med Assoc. 2007 Jul;105(7):380, 382-5.
8
Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):114-9. doi: 10.1016/0002-9378(95)90095-0.
9
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2.
10
Hormonal intrauterine devices.
Ann Med. 1993 Apr;25(2):143-7. doi: 10.3109/07853899309164158.
引用本文的文献
1
Management of endometrial modifications in perimenopausal women.
Clujul Med. 2015;88(2):101-10. doi: 10.15386/cjmed-421. Epub 2015 Apr 15.
2
Morphological and Ultrastructural Changes in Human Endometrium Following Low-Dose Levonorgestrel Contraceptive Intrauterine Systems (LNG-IUS-12) 13.5 mg.
J Obstet Gynaecol India. 2015 Oct;65(5):323-7. doi: 10.1007/s13224-014-0620-6. Epub 2014 Oct 29.
3
Efficacy of levonorgestrel releasing intrauterine system for the treatment of menorrhagia due to benign uterine lesions in perimenopausal women.
J Midlife Health. 2012 Jan;3(1):20-3. doi: 10.4103/0976-7800.98812.
4
Hormonal contraception--what kind, when, and for whom?
Dtsch Arztebl Int. 2011 Jul;108(28-29):495-505; quiz 506. doi: 10.3238/arztebl.2011.0495. Epub 2011 Jul 18.
本文引用的文献
1
Hormonal contraception and risk of venous thromboembolism: national follow-up study.
BMJ. 2009 Aug 13;339:b2890. doi: 10.1136/bmj.b2890.
2
Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
Contraception. 2009 Jul;80(1):84-9. doi: 10.1016/j.contraception.2009.01.004. Epub 2009 Feb 27.
3
Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis.
Obstet Gynecol. 2009 May;113(5):1104-1116. doi: 10.1097/AOG.0b013e3181a1d3ce.
4
Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators.
Gynecol Endocrinol. 2009 Feb;25(2):67-73. doi: 10.1080/09513590802531120.
5
A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system.
Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):128-9. doi: 10.1016/j.ejogrb.2008.12.012. Epub 2009 Jan 31.
6
Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
Arch Gynecol Obstet. 2009 Jul;280(1):39-42. doi: 10.1007/s00404-008-0871-5. Epub 2008 Dec 10.
7
The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
J Minim Invasive Gynecol. 2008 Nov-Dec;15(6):735-8. doi: 10.1016/j.jmig.2008.08.011.
8
Advances in treatment options of endometriosis.
Gynecol Obstet Invest. 2009;67(2):81-91. doi: 10.1159/000163071. Epub 2008 Oct 16.
9
Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
Gynecol Oncol. 2008 Oct;111(1):68-73. doi: 10.1016/j.ygyno.2008.06.014. Epub 2008 Aug 6.
10
Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
Climacteric. 2008 Jun;11(3):252-7. doi: 10.1080/13697130802163168.
Zotero 插件